Save up -80% on Palivizumab

Note: this is a drug discount program, not an insurance plan.

RX BIN: 015558
RX PCN: HT
Group ID: DDN6600
Card Holder ID: DDN6600

Pharmacists and Patients support.

2018 Price of Palivizumab

Synagis

$1566

100 mg/mL intramuscular solution

* price without discount in nearest pharmacy. Price may vary.

Claim your free Palivizumab discount card

We offer free Palivizumab coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Palivizumab every time. What are you waiting for? Claim your prescription drug card now!

Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time

Palivizumab volume of distribution

About RX24Drugs

Discount Cards 16,000+

Clients Benefit 29%

Total savings $4,735,080

What is Palivizumab

Humanized monoclonal antibody (IgG1k) produced by recombinant DNA technology, directed to an epitope in the A antigenic site of the F protein of respiratory syncytial virus (RSV). Synagis is a composite of human (95%) and murine (5%) antibody sequences. The human heavy chain sequence was derived from the constant domains of human IgG1 and the variable framework regions of the VH genes Cor (1) and Cess (2). The human lightchain sequence was derived from the constant domain of Ck and the variable framework regions of the VL gene K104 withJk-4. Palivizumab is expressed from a stable murine (mouse) myeloma cell line (NS0). Palivizumab is composed of to heavy chains (50.6 kDa each) and two light chains (27.6 kDa each), contains 1-2% carbohydrate by weight and has a molecular weight of 147.7 kDa +/- 1 kDa (MALDI-TOF)

Palivizumab mechanism of action

Palivizumab binds to the fusion glycoprotein of RSV. This prevents its binding and uptake by host cellular receptors.

Dosage forms of Palivizumab

FormRouteStrength
Injection, solutionintramuscular100 mg/mL
Injection, solutionintramuscular50 mg/.5mL
Powder and solvent for solution for injectionIntramuscular use100 mg
Prescription Generics

false

International Brands

Synagis

Synonyms

anti-RSV Synagis

Manufacturers

Abbvie Corporation

CAS number

188039-54-5

UNII

DQ448MW7KS

State

liquid

Affected organisms

Indication of Palivizumab

For prophylaxis of respiratory diseases casued by respiratory syncytial virus.

Toxicity of Palivizumab

RX24 Drugs Disclaimer: before buying a Palivizumab on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.

Get lower price on Palivizumab now!